| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |